Ivy Micro Cap Growth Fund Class C (IGWCX)

24.87
Net Asset Value
+0.57%
1 Day
+6.01%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
2.35%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks to provide growth of capital. The fund seeks to achieve its objective by investing, under normal circumstances, at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of micro capitalization companies. Micro capitalization companies typically are companies with float-adjusted market capitalizations below $1 billion at the time of acquisition.

Performance

1 month+2.11% 3 years+15.54%
3 months+2.91% 5 years+16.91%
1 year+2.92% Since inception+19.51%
Data through --

Peer Comparisonvs. Small growth

 IGWCXCategory
Performance 5-yr return+16.91%+15.12%
Expense ratio2.35%1.37%
Risk 5 year sharpe ratio0.770.94
Net assets$226.2M$817.7M
Average market cap$628.6M$2.9B
Average P/E--28.0
Portfolio turnover47%47%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyIvy Funds
Fund manager & tenurePaul Ariano / 6 Years
Minimal initial investment$750.00
Minimum IRA investment--

Holdings

U.S. stock95.63%
Cash2.28%
International stock1.59%
Fixed income0.50%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 14.90%
Hardware 14.00%
Business service 13.23%
Media 10.15%
Consumer service 8.55%
Top 10 Holdings
Portfolio weighting
-- 3.57%
RGEN Repligen Corp2.35%
AERI Aerie Pharmaceuticals Inc1.94%
QDEL Quidel Corp1.81%
TWOU 2U Inc1.81%
CALD Callidus Software Inc1.76%
NLNK NewLink Genetics Corp1.62%
RTRX Retrophin Inc1.58%
PTX Pernix Therapeutics Holdings Inc1.55%
QTWO Q2 Holdings Inc1.55%

To view my watchlist

Not a member yet?

Sign up now for a free account